Clinical Significance of Tissue Factor Pathway Inhibitor 2, a Serum Biomarker Candidate for Ovarian Clear Cell Carcinoma
Noriaki Arakawa(National Institute of Health Sciences), Etsuko Miyagi(Yokohama City University Hospital)
Cited by 38
Related Papers
Stratifin as a novel diagnostic biomarker in serum for diffuse alveolar damage
|Nature Communications|2022|29
Stratifin as a Novel Diagnostic Biomarker in Serum for Diffuse Alveolar Damage
|Research Square|2021|1